Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Connective Tissue Cell Types

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcome of Standardbred racehorses following femoropatellar arthroscopy for osteochondrosis dissecans.

Veterinary surgery : VS·2025

Same author

Distal interphalangeal joint capsule enthesopathy of the middle phalanx and articular cartilage loss.

Equine veterinary journal·2025

Same author

Metabolic heterogeneity exists across equine distal limb tendons and ligaments in healthy, metabolically normal horses.

American journal of veterinary research·2025

Same author

Western performance horses with fetlock lameness demonstrate radiographic evidence of chronic exercise remodelling.

Equine veterinary journal·2025

Same author

Severity, distribution and postoperative therapy are not predictors of return to work in western performance horses with stifle chondromalacia.

Veterinary surgery : VS·2025

Same author

Acute tear versus chronic-degenerated rotator cuff pathologies are associated with divergent tendon metabolite profiles.

Connective tissue research·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

Published on: December 9, 2015

Cell-based therapies for equine joint disease.

David D Frisbie¹, Matthew C Stewart

¹Equine Orthopaedic Research Center, Department of Clinical Sciences, College of Veterinary Medicine and Biological Sciences, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523, USA. David.Frisbie@ColoState.EDU

The Veterinary Clinics of North America. Equine Practice

|August 30, 2011

Summary

Joint disease in horses, like arthritis, is difficult to treat due to cartilage's poor repair capacity. Cell-based therapies show promise for repairing damaged cartilage in equine joint disease.

More Related Videos

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

Related Experiment Videos

Last Updated: May 29, 2026

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

Published on: December 9, 2015

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Applying a Three-dimensional Uniaxial Mechanical Stimulation Bioreactor System to Induce Tenogenic Differentiation of Tendon-Derived Stem Cells

Published on: August 1, 2020

Area of Science:

Veterinary Medicine
Regenerative Medicine
Equine Science

Background:

Joint disease significantly impacts performance horses, leading to wastage.
Articular cartilage has limited intrinsic repair capacity, complicating treatment.
Current therapies primarily manage clinical signs rather than addressing the root cause.

Purpose of the Study:

To review cell-based therapies for treating equine joint disease.
To explore the potential of regenerative medicine in equine osteoarthritis.
To present findings from experimental, human, and equine studies.

Main Methods:

Literature review of experimental models, human clinical studies, and equine case data.
Focus on cell-based therapeutic strategies for articular cartilage repair.
Analysis of current research on regenerative treatments for joint disease.

Main Results:

Cell-based therapies offer a potential solution to overcome cartilage repair limitations.
Experimental and human studies provide a foundation for equine applications.
Available equine data suggests potential efficacy but requires further investigation.

Conclusions:

Cell-based therapies represent a promising avenue for treating equine joint disease.
Regenerative medicine holds potential to improve cartilage repair and horse welfare.
Further research and clinical trials are needed to optimize equine cell therapy protocols.